ArticleTobacco control2025
Eradication of commercial tobacco related disease and death.
Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Cotinine Promotes Cancer Cell Proliferation and mEnvironment & health (Washington, D.C.) · 2026Article
- Effectiveness and implementation of an indigenous-led mailed smoking cessation intervention for aboriginal and torres strait islander people: outcomes of a hybrid type 1 trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026Article
- "Stealth Vaping Is Everywhere": The Narratives of Young Māori Adults in New Zealand.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025Article
- Two decades of global tobacco control: time for a rethink.Internal and emergency medicine · 2025Article
- Oversimplification of a complex public health issue that serves exploitative industry interests.Addiction (Abingdon, England) · 2025Article
- Engagement of Indigenous peoples in commercial tobacco reform strategies: a scoping review protocol.BMJ open · 2025Article
- Building love and justice, ending harms: a framework for abolishing the tobacco and nicotine industry.Health promotion international · 2025Article
- Colonial harm in new packaging: Indigenous critiques of the tobacco industry's 'harm reduction' rhetoric.Health promotion international · 2025Article
- Footprints in time: individual, social, and environmental factors and never-use of e-cigarettes among Indigenous adolescents.Health promotion international · 2025Article
- Longitudinal Study of Indigenous Children: adolescent never smoking and associations with individual, social, and environmental factors.Health promotion international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The eradication of the commercial tobacco industry is a crucial goal for health and well-being, particularly from a public health and health justice perspective. The term 'eradication' is applied in epidemiology to mean the process and outcome of elimination of the-commercial tobacco industry as a human-made-agent of disease and death. In this commentary, we outline why the eradication of the tobacco industry is necessary, urgent and realistic.The potential impact of eradication of the industry is substantial. Without the industry and the commercial tobacco that it produces, it is expected that globally over 22 000 lives will be saved daily (over 8 million annually), and life expectancy will increase. The human right to health underscores the need for tobacco industry accountability for the harms it causes and given the enormous human and financial costs, it is time for action towards eradication of the industry.The tobacco industry's opposition to tobacco control, particularly strategies focused on market supply and industry reform, has been fierce. Their strategies have involved circumventing, attacking and undermining public health measures to preserve profits. However, with insights learnt from over 70 years of incremental successes in reducing commercial tobacco use, we know that through comprehensive and locally tailored eradication strategies involving legislation, regulation and public health initiatives across multiple levels of governments, we can overcome the resistance from the tobacco industry and their affiliates. Given the cost of commercial tobacco and the ever-growing global consensus on its harms, the time to act is now.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.